Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
filingDate |
2017-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c035d3660825275c74c647331f0743c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddfcfa7f609f7be482ffcd64bab253bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_031ebb2943255bc6cbb8629da2b6d2c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feb6d8c57fb549a0d32f456381f5d1c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4838c7caf05760118ecd98d53b4b77a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_571d790e60f8c52da323e4d6997ae3f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac338f51f0f5349757af6345d4d825f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3714d96db3fef3df68df0adfd634a7a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4822343d0c8554dba863c5b8792c6990 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cb3fabd5b49d7b388392cb7a64cdcdf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b6840df5b4ba406a4c95e808b8da04a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_834cd90451ae0e63fff003d33c8ed5ea |
publicationDate |
2018-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2017286380-A1 |
titleOfInvention |
Azabenzimidazole derivatives as PI3K beta inhibitors |
abstract |
The present invention relates to azabenzimidazole derivatives of Formula (I) (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as pI3Kβ inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active 10 ingredient as well as the use of said compounds as a medicament. |
priorityDate |
2016-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |